Search

everythinglearnresearchcommunity

for

Search:↓

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Females had more chemotherapy side effects than males, with many being preventable.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Injecting 2 ml of TEEV every 4 weeks is better because it has the same benefits but fewer side effects.

Anti-androgens are safe and effective for treating moderate to severe adult female acne.

Combining low-dose dutasteride with finasteride improved a man's hair loss.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Dutasteride is more effective for male pattern baldness than finasteride, and black cohosh extract BNO 1055 is as effective as conjugated estrogens in treating postmenopausal symptoms, with added benefits in reducing sweating and mental symptoms.

Dutasteride is safe and effective for treating hair loss, but may decrease libido.